A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
about
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragmentAn Antibody as Surrogate Receptor Reveals Determinants of Activity of an Innate Immune Peptide AntibioticVirus outbreaks in chemical and biological sensorsPhage display of peptide / major histocompatibility class I complexes.Antibodies to human fetal erythroid cells from a nonimmune phage antibody libraryUse of proteoliposomes to generate phage antibodies against native AMPA receptor.The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library.Molecular studies of anti-HLA-A2 using light-chain shuffling: a structural model for HLA antibody binding.Display technologies: application for the discovery of drug and gene delivery agents.Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor.Discovery of internalizing antibodies to tumor antigens from phage libraries.Selection and characterization of cell binding and internalizing phage antibodies.Modulation of CD4 T cell function by soluble MHC II-peptide chimeras.An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.Examining variable domain orientations in antigen receptors gives insight into TCR-like antibody design.Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody.Expanding the targets available to therapeutic antibodies via novel disease-specific markers.Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters.T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.Supernatural T cells: genetic modification of T cells for cancer therapy.Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptorsNovel antibodies as anticancer agents.The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradationTargeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.T-cell-receptor-like antibodies - generation, function and applications.Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.Epitopes of the class I major histocompatibility complex (MHC-I) recognized in the syngeneic or allogeneic context predominantly linked to antigenic peptide loading to its binding groove.Therapeutic Antibodies against Intracellular Tumor AntigensConstruction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?
P2860
Q27322455-A866F041-E8C0-428E-9661-A635ADDA1B3FQ27664451-C19CDFEC-7C96-4CB0-974D-3A1A52590687Q28395028-BB3592C9-A584-49CF-B3BA-81CE571298CEQ30651735-4E6C8F42-7302-45A3-9030-607ED742657AQ30659936-1F52EFD7-F30F-4811-82FB-B81798CD6A4EQ30842128-2008A203-DC5E-4DEC-A4F3-17A3EC764843Q30860547-934F3839-EA03-457E-B952-095335BF8F94Q33199161-484152D3-AAD1-4B92-8895-71D6EC51B8C7Q33264491-0EBEE40C-C0E0-49C2-A81B-B4FFA9FB7461Q33992114-25B84E4A-BDF0-4422-9D4A-3DD1977F2E92Q34035564-FB3D4EA2-9D23-4FE8-AA81-EFC349F9FF8AQ34042430-13F40ED0-23FA-44F0-AD33-A5B442F3E98AQ34114794-4BC41537-11F0-4305-9DF3-5DFC5557521EQ34280931-91FFAEA2-07E0-47D3-9B0B-BA313D5A5E2BQ34560511-8F9FE7F6-4C50-457B-A8C8-8036EA2FBFF9Q34923734-993BCF57-4006-45F7-B625-A91BDA315317Q35173245-C0102F25-D9D2-447B-96D2-08AB1D355FD9Q35262045-CD29A9BE-38A4-4C55-872E-33660B8BF7B6Q35924840-2C8EAB64-1069-468D-9305-D0AA63126C36Q36027414-2FFAA29E-D561-4AC3-A115-F309AA4C9071Q36119688-A5589801-A100-4CCA-AF2D-D6C3EEAC11DDQ36142259-B878F66A-FE79-431A-B1C7-0E399C4F9766Q36279987-D1775937-7A88-4D19-A63C-9546CFB3860AQ36297606-33E27ED9-050E-4280-BE38-CBCF5D2BD49EQ36317151-138DED4F-3AF1-4770-832C-8FD183507FBAQ36328805-CFC66BAC-2D6E-4AB2-94EA-EE8EDEC3B6D3Q36368410-345A5749-FD99-4ABB-92B7-94382A311839Q36398857-69F02FD2-76D2-4FB3-9A4E-DB67F2924D97Q36832141-30326DB9-2BF3-45AA-936C-8F1478ED9451Q36983796-3FA3B70A-398A-4C8C-A063-A0927A0870CCQ37192915-3E483801-ACC1-495A-84B1-8CEE3BF52478Q37337350-FF3F7C65-4F4A-4409-B4D6-89BAE4607CC8Q37952806-6B6551F7-9A0C-4A37-8DF9-9E9302284194Q37987723-EEEC8D37-10E4-4D79-A3FA-2C081FC45204Q39930758-4862E2EF-4534-49F1-9501-FE9C051F1392Q40196365-7FAD4B21-F631-413D-A4E7-A26D7F6B15A0Q40249631-F4EDF562-6149-474D-B152-960AFFBA7A44Q41462883-9A0EC86F-AE89-4D88-80DE-91A9A234672BQ43448245-FBB7BACF-500B-40E6-8C6E-9289B6AE3C67Q45012658-DD1D193B-77EC-45BE-A330-CAD50D3CBB7F
P2860
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A recombinant antibody with th ...... ricted specificity of T cells.
@ast
A recombinant antibody with th ...... ricted specificity of T cells.
@en
type
label
A recombinant antibody with th ...... ricted specificity of T cells.
@ast
A recombinant antibody with th ...... ricted specificity of T cells.
@en
prefLabel
A recombinant antibody with th ...... ricted specificity of T cells.
@ast
A recombinant antibody with th ...... ricted specificity of T cells.
@en
P2093
P2860
P356
P1476
A recombinant antibody with th ...... tricted specificity of T cells
@en
P2093
B E Hansen
P S Andersen
P2860
P304
P356
10.1073/PNAS.93.5.1820
P407
P577
1996-03-01T00:00:00Z